Loading clinical trials...
Loading clinical trials...
An Evaluation of Long-Term Protection Against Hepatitis B Virus Infection: Response of Alaska Native Children and Adolescents Who Received the Primary Recombinant Hepatitis B Vaccine Series Beginning at Birth to an Additional Dose of Vaccine
Conditions
Interventions
hepatitis B vaccine
Locations
1
United States
Alaska Native Medical Center
Anchorage, Alaska, United States
Start Date
May 1, 2001
Primary Completion Date
March 1, 2005
Completion Date
March 1, 2008
Last Updated
September 27, 2012
NCT06632444
NCT07024641
NCT02815891
NCT07442760
NCT06953479
NCT06819917
Lead Sponsor
Centers for Disease Control and Prevention
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions